Alnylam to sell 5.1 million shares

New York, Jan. 23 - Alnylam Pharmaceuticals, Inc. said it plans to sell 5,115,961 shares of common stock in an off-the-shelf deal.

Morgan Stanley & Co. Inc. is bookrunner. Banc of America Securities LLC is co-lead manager and co-managers are Piper Jaffray & Co., SG Cowen & Co., LLC and Rodman & Renshaw, LLC.

The sale has a greenshoe of 767,394 shares.

Alnylam stock closed down $0.33 at $14.66 ahead of the announcement, which was made after trading had finished.

Alnylam is a Cambridge, Mass., therapeutics company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.